Gilead Considering Ebola Drug as Potential Coronavirus Treatment
As fears about the coronavirus outbreak in China continue to grow, a number of companies have started working on potential vaccines. Gilead (NASDAQ: GILD) announced Thursday that it was evaluating whether its experimental Ebola treatment could be used to treat the coronavirus.
In an attempt to prevent the virus from spreading, China has imposed travel restrictions on millions of people across the two cities at the center of the outbreak. The virus has already killed 18 people and infected more than 600. And although there has only been a single diagnosed case in the U.S. so far, authorities here are worried about the infection getting a foothold.
Image source: Getty Images.
Source Fool.com
